GENE ONLINE|News &
Opinion
Blog

Novartis
Trials & Approvals Prostate Specific Membrane Antigen
Novartis’ Pluvicto Continues Winning Streak In Prostate Cancer Indication
2022-12-07
Partnerships Malaria
Novartis Shifts Gear To Phase 3 For Anti-Malaria Drug
2022-11-24
Policy Patent Infringement
Novartis Ordered to Pay $177.8 million to Plexxikon for Patent Infringements
2022-10-03
Trials & Approvals Chronic Myeloid Leukemia
Novartis’ Treatment for Rare Cancer Wins European Commission’s Approval
2022-08-29
M&A Novartis
Novartis Split: Sandoz Spin Off Forming A Standalone Company
2022-08-25
Trials & Approvals AAV Gene Therapy
Novartis Reported Two Deaths Following Zolgensma Gene Therapy
2022-08-12
Special BIO Asia-Taiwan
BIO Asia-Taiwan 2022: The Future Of CGT In Taiwan
2022-08-08
Special
As Private Equity Sale Becomes Less Likely, Novartis May Gravitate Towards Sandoz Spinoff
2022-07-04
Funding Cell and Gene Therapy
These Pharma Companies Are Laying Off Employees Due to Restructuring
2022-06-30
Trials & Approvals Lung Cancer
Novartis’s Lung Cancer Drug Approved for Marketing in Europe
2022-06-23
Licensing Multiple Sclerosis
US Court Rules Novartis Blockbuster Multiple Sclerosis Drug’s Patent Invalid
2022-06-22
Licensing CDMO
Novartis and Samsung Biologics Sign Low-Profile $81 Million Deal
2022-06-10
Special ASCO
ASCO 2022: AstraZeneca, Pfizer, Novartis Share Key Data on Breast Cancer Therapeutics
2022-06-07
Trials & Approvals CAR T-cell Therapy
Novartis CAR-T Cell Therapy Receives FDA Approval for Third Indication to Treat Follicular Lymphoma
2022-05-30
Regulatory BeiGene
EMA Begins Review of BeiGene, Novartis’s PD-1 Antibody for Esophageal and Lung Cancer
2022-04-13
1 2 3 4 … 7
LATEST
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top